HQY
Fiscal year ends January Quarters are offset from the calendar — Q1 is Feb–Apr

HealthEquity, Inc. is a technology-enabled services company that manages tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) for consumers in the United States. The company administers HSAs, flexible spending accounts (FSAs), and health reimbursement arrangements (HRAs), providing payment processing, personalized benefit information, and access to a healthcare marketplace. HealthEquity offers investment services through its subsidiary HealthEquity Advisors, LLC, including an automated investment advisory service called Advisor, which provides self-driven, GPS, and AutoPilot portfolio management options. The company reaches consumers primarily through relationships with employers, benefits brokers, and a network of health plans and benefits administrators. It earns revenue from service fees, custodial fees, and interchange fees from payment card transactions. In fiscal 2025, the company acquired the BenefitWallet HSA portfolio from Conduent Business Services, LLC.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Financial Data & Stock Exchanges Homepage healthequity.com
Sector Financial Services IR page ir.healthequity.com
Tags
health savings accounts, flexible spending accounts, health reimbursement arrangements, consumer-directed benefits, payment processing, investment advisory, automated investment, benefits administration, tax-advantaged accounts, healthcare marketplace, HealthEquity Advisors LLC, Advisor, BenefitWallet, Conduent Business Services LLC
Press page —

Metrics

Valuation  
Market cap $ 7.489B
Market cap (USD) $ 7.489B
P/E 32.61
PEG —
P/BV 3.76
P/S 5.50
P/OCF 15.28
P/FCF 15.36
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.2%
ROI 7.0%
ROIC 8.2%
Profit margin 16.4%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 46.8%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 18
Quality score 50.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Revenue 1.313B 1.2B 999.587M 861.748M 756.556M 733.57M 531.993M 287.243M 229.525M 178.37M 126.786M 87.855M 62.015M
Net profit 215.201M 96.703M 55.712M -26.143M -44.289M 8.834M 39.664M 73.899M 47.362M 26.376M 16.613M 10.166M 1.233M
Free cash flow 455.125M 337.772M 241.132M 147.279M 132.087M 168.526M 97.724M 109.553M 76.244M 41.946M 24.165M 13.334M 16.42M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014
Share price 91.61 95.95 70 61.64 44.24 85.36 68.65 61.08 52.01 46.46 25.03 25.45 —
Price performance 12m -0.05 0.37 0.14 0.39 -0.48 0.24 0.12 0.17 0.12 0.86 -0.02 — —

Filed figures

Figure Jan 2017 Jan 2018 Jan 2019 Jan 2020 Jan 2021 Jan 2022 Jan 2023 Jan 2024 Jan 2025 Jan 2026
Balance sheet detail
Trade receivables (USD) 17M 21.6M 25.7M 70.9M 72.8M 87.4M 96.8M 105M 118M 124M
↳ YoY growth +18.8% +27.1% +18.8% +176.1% +2.7% +20.1% +10.8% +8.3% +12.5% +4.8%
↳ 5y CAGR +35.1% +50.9% +38.4% +38.8% +35.0% +32.5% +10.7% +11.2%
Borrowings, current (USD) — — 0.00 39.1M 62.5M 8.75M 17.5M 0.00 0.00 0.00
Borrowings, non-current (USD) — — 0.00 1.18B 924M 922M 908M 875M 1.06B 957M
Lease liabilities (USD) — — — 80.4M 88.3M 77.4M 69.1M 58.2M 52.2M 44.1M
Cash and deposits (USD) 140M 199M 362M 192M 329M 225M 254M 404M 296M 319M
Intangible assets (USD) 65M 83.6M 79.7M 783M 767M 973M 936M 836M 1.2B 1.1B
Right-of-use assets (USD) — — — 83.2M 89.5M 63.6M 56.5M 48.4M 43.2M 36.3M
Net debt (borrowings + leases - cash) (USD) — — -361M 1.11B 746M 783M 740M 529M 813M 683M
Cash flow detail
Operating cash flow (USD) 45.6M 81.7M 113M 105M 182M 141M 151M 243M 340M 457M
Purchases of property, plant and equipment (USD) -3.65M -5.46M -3.87M -7.29M -13.1M -8.91M -3.37M -1.69M -2.08M -1.97M
Purchases of intangible assets (USD) -9.03M -27.9M -11.2M -34.8M -83.9M -128M -116M -44.4M -503M -46.8M
Change in receivables (cash effect) (USD) -2.73M -4.73M -4.31M -5.01M -413,000 -11.2M -9.57M -8.06M -13.1M -5.69M
Change in inventories (cash effect) (USD) 28,000 377,000 — — — — — — — —
Change in payables (cash effect) (USD) 567,000 -581,000 863,000 -3.84M — — — — — —
Dividends paid (cash effect) (USD) 0.00 — — — — — — — — —
Share buybacks (cash effect) (USD) — — — — — — 0.00 0.00 -121M -299M
Interest paid (cash effect) (USD) -213,000 -203,000 -203,000 -21.8M -27.7M -16.1M -43.6M -49.6M -58.6M -52.2M
Income taxes paid (cash effect) (USD) -863,000 -27,000 -587,000 -9.28M 6.02M 5.63M -1.53M -35.4M -26.1M -8.04M
Share-based compensation (USD) 8.4M 14.3M 21.1M 39.8M 42.9M 52.8M 62.6M 77.2M 96.4M 73.1M
Operating cash flow before change in receivables (USD) 48.3M 86.4M 118M 110M 182M 152M 160M 251M 353M 463M
Free cash flow (OCF - PPE - intangibles) (USD) 32.9M 48.3M 98.4M 62.9M 84.7M 3.91M 31.5M 197M -166M 408M
Income detail
Research and development expense (USD) 22.4M 27.4M 35.1M 77.6M 125M 157M 193M 219M 240M 263M
↳ 5y CAGR +45.3% +37.5% +49.2% +49.3% +47.7% +47.8% +44.2% +25.3% +16.0%
Total comprehensive income (USD) 26.3M 47.3M 73.9M 39.7M 8.83M -44.3M -26.1M 55.7M 96.7M 209M
Comprehensive income to owners (USD) 26.3M 47.3M 73.9M 39.7M 8.83M -44.3M -26.1M 55.7M 96.7M 209M
Provision for credit losses (USD) 35,000 133,000 240,000 1M 3.4M 3.3M 2.1M 1.7M 200,000 800,000
Credit cost ratio (credit losses / average receivables) (%) 0.2% 0.7% 1.0% 2.1% 4.7% 4.1% 2.3% 1.7% 0.2% 0.7%
Reported Mar 30, 2017 Mar 28, 2018 Dec 5, 2019 Mar 31, 2020 Mar 31, 2022 Mar 31, 2022 Mar 18, 2025 Mar 18, 2025 Mar 18, 2025 Mar 17, 2026

Operating KPIs — quarters

KPI Oct 24 Jan 25 Apr 25 Jul 25 Oct 25 Jan 26 Apr 26 Jul 26
Customers 16.5M 17M 17.1M 17.1M 17.3M 17.8M 17.8M 17.8M
↳ YoY growth +7.7% +8.5% +6.6% +5.3% +5.0% +4.5% +4.2% +3.6%
Reported Dec 9, 2024 Feb 18, 2025 Jun 3, 2025 Sep 2, 2025 Dec 3, 2025 Feb 17, 2026 May 28, 2026 Aug 27, 2026

Operating KPIs — years

KPI Jan 2021 Jan 2022 Jan 2023 Jan 2024 Jan 2025 Jan 2026
Customers 12.8M 14.4M 14.9M 15.7M 17M 17.8M
↳ YoY growth +0.2% +12.4% +3.6% +5.2% +8.5% +4.5%
Reported Mar 15, 2021 Feb 22, 2022 Feb 14, 2023 Feb 21, 2024 Feb 18, 2025 Feb 17, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

DRAPER, Utah, Nov. 03, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its third quarter of fiscal 2027, after the closing of regular stock market trading on Tuesday, December 1, 2026. Following the news release, HealthEquity management will host a conference call for investors on Tuesday, December 1, 2026, at 4:30 p.m. Eastern Time to review the Company’s third quarter results.

| HealthEquity Third Quarter Fiscal Year 2027 Results Conference Call |

| Date: | | December 1, 2026 |

| Time: | | 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time |

| Dial-In: | | 1-833-862-0280 (US and Canada) 1-412-714-2048 (International) |

| Conference ID: | | HealthEquity |

| Webcast: | | ir.healthequity.com |

| | | |

A replay of the conference call will be available on the Company’s website at ir.healthequity.com.

About HealthEquity

HealthEquity and its subsidiaries administer HSAs and various other consumer-directed benefits for over 17 million accounts, working in close partnership with employers, benefits advisors, and health and retirement plan providers who share our unwavering commitment to our mission of saving and improving lives by empowering healthcare consumers. Through cutting-edge solutions, innovation, and a relentless focus on improving health outcomes, we empower individuals to take control of their healthcare journey while ultimately enhancing their overall well-being. For more information, visit www.healthequity.com.

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance that these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

  • our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners;

  • our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;

  • our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs;

  • the impact of fraudulent account activity involving our member accounts or our third-party service providers on our reputation and financial results;

  • our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;

  • the significant competition we face and may face in the future, including from those with greater resources than us;

  • our reliance on the availability and performance of our technology and communications systems;

  • potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;

  • the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;

  • our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;

  • our reliance on partners and third-party vendors for distribution and important services;

  • our ability to develop and implement updated features for our technology platforms and communications systems; and

  • our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2026, and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations Contact: Richard Putnam 801-727-1000 [email protected]

Primary Logo

  • Intra

  • 3 mo.

  • 6 mo.

  • 1 yr.

Intraday stock price graph

3 month stock price graph

6 month stock price graph

12 month stock price graph

INVESTOR RELATIONS CONTACT

Richard Putnam

The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026. The responsibilities of the Chief Commercial Officer will be redistributed to other members of the Company’s management team.

In consideration of Mr. Fiore’s execution, delivery, and non-revocation of the release of claims against the Company and its subsidiaries and affiliates substantially in the form attached to his employment agreement, and his continuing compliance with certain restrictive covenants contained therein, Mr. Fiore will receive the previously negotiated severance payments and benefits set forth in his employment agreement, as detailed in the Company’s most recent proxy statement filed with the Securities and Exchange Commission on May 13, 2026, and his outstanding equity awards will be treated in a manner consistent with the terms of the 2014 Stock Incentive Plan, the 2024 Stock Incentive Plan, and his applicable award agreements, each as previously filed.

- 2 -

DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody’s Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept. 24, 2026. Heuland will also serve on the Audit and Risk Committee and Cybersecurity and Technology Committee of the Board. Her appointment expands the Board to 11 directors, nine of whom are independent.

“Noémie has built her career at the intersection of finance and technology, with deep experience leading through periods of growth and change,” said Robert Selander, Chairman of the Board. “Her financial and strategic perspective will be valuable as we continue to scale HealthEquity, invest for the future and navigate the opportunities that come with our next phase of growth.”

“HealthEquity has built a strong business grounded in an important mission: helping people better manage and pay for healthcare,” said Heuland. “I look forward to contributing my experience as the Company continues to grow, innovate, and create value for its members, clients and shareholders.”

Heuland has served as Chief Financial Officer of Moody’s since April 2024. Before becoming CFO of Moody’s, Heuland was the Chief Financial Officer at Dayforce, Inc. from October 2020 to February 2024. Before joining Dayforce, Heuland spent 12 years working for SAP in finance leadership roles. Heuland holds an M.S. in Finance and Accounting from Nantes Business School of Management, now known as Audencia. Ms. Heuland is a Certified Public Accountant.

About HealthEquityHealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for nearly 18 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to save and improve lives by empowering healthcare consumers. For more information, visit www.healthequity.com.

Investor Relations Contact: Richard Putnam 801-727-1000 [email protected]

Primary Logo

  • Intra

  • 3 mo.

  • 6 mo.

  • 1 yr.

Intraday stock price graph

3 month stock price graph

6 month stock price graph

12 month stock price graph

INVESTOR RELATIONS CONTACT

Richard Putnam

Prompts

HealthEquity, Inc. (ticker HQY), listed in United States.

Company History

Date Change Detail
Aug 8, 2019 Acquired Acquired Wageworks, Inc. (CIK 1158863). Its filings from before the deal are on its own company page, not shown here.

ETFs Holding HealthEquity, Inc.

ETF Weight in ETF Shares Market value As of
TMFM 5.02% 61,962 $ 5.982M Aug 31, 2026
TMFS 4.28% 25,839 $ 2.494M Aug 31, 2026
SMCO 2.77% 38,658 $ 4.043M Nov 17, 2026
FFLS 2.29% 10,272 $ 991.659K Aug 31, 2026
MEDI 1.60% 6,662 $ 686.519K Nov 12, 2026
IVSS 1.50% 4,476 $ 404.272K Jun 30, 2026
FFOX 1.42% 37,902 $ 3.423M Jun 30, 2026
SSMG 1.21% 385 $ 38.735K Jul 31, 2026
FFND 1.14% 11,652 $ 1.125M Aug 31, 2026
FSEG 0.73% 460 $ 41.547K Jun 30, 2026
MMSC 0.70% 3,346 $ 349.925K Nov 16, 2026
FESM 0.65% 416,088 $ 37.581M Jun 30, 2026
SCDS 0.63% 568 $ 57.845K Nov 17, 2026
JSML 0.54% 19,521 $ 1.964M Jul 31, 2026
PSC 0.46% 119,817 $ 10.822M Jun 30, 2026
FLDZ 0.41% 184 $ 16.619K Jun 30, 2026
MKTN short -0.35% -4,110 $ -371.215K Jun 30, 2026
RESM 0.35% 140 $ 12.645K Jun 30, 2026
MSSM 0.30% 22,473 $ 2.17M Aug 31, 2026
FTQI 0.28% 25,917 $ 2.71M Nov 16, 2026
RUSC 0.25% 2,175 $ 196.446K Jun 30, 2026
SEIS 0.23% 14,609 $ 1.319M Jun 30, 2026
ESUM 0.22% 3,924 $ 394.794K Jul 31, 2026
SAGP 0.20% 1,665 $ 150.383K Jun 30, 2026
DFAS 0.19% 620,439 $ 63.936M Nov 12, 2026
AVIE 0.18% 293 $ 30.642K Nov 16, 2026
FELV 0.15% 54,318 $ 4.906M Jun 30, 2026
FHEQ 0.14% 12,769 $ 1.285M Jul 31, 2026
VFQY 0.10% 5,138 $ 496.023K Aug 31, 2026
FMDE 0.09% 73,002 $ 6.594M Jun 30, 2026
FELC 0.09% 76,575 $ 6.916M Jun 30, 2026
FSML 0.08% 1,135 $ 102.513K Jun 30, 2026
AVMC 0.08% 4,252 $ 444.674K Nov 16, 2026
JMEE 0.08% 23,208 $ 2.364M Nov 17, 2026
SMDX 0.07% 865 $ 90.462K Nov 17, 2026
FELG 0.06% 36,101 $ 3.261M Jun 30, 2026
DFAT 0.05% 167,663 $ 17.278M Nov 12, 2026
DFUV 0.05% 74,082 $ 7.634M Nov 12, 2026
FEAC 0.05% 130 $ 11.742K Jun 30, 2026
FYEE 0.04% 959 $ 96.485K Jul 31, 2026
IALT 0.03% 21,005 $ 2.197M Nov 16, 2026
DFAC 0.03% 254,817 $ 26.259M Nov 12, 2026
DXUV 0.03% 17,951 $ 1.85M Nov 12, 2026
DFSU 0.03% 6,612 $ 681.367K Nov 12, 2026
DCOR 0.02% 85,314 $ 8.792M Nov 12, 2026
SYZ 0.02% 115 $ 10.387K Jun 30, 2026
DFAU 0.01% 18,731 $ 1.93M Nov 12, 2026
DFUS 0.01% 25,310 $ 2.608M Nov 12, 2026
AVSU 0.01% 594 $ 62.121K Nov 16, 2026
AVLC 0.01% 1,514 $ 158.334K Nov 16, 2026
EBI 0.01% 565 $ 54.545K Aug 31, 2026
AVUS 0.00% 1,131 $ 118.28K Nov 16, 2026
GVLU 0.00% 24 $ 2,509.92 Nov 17, 2026